91 results on '"Maurer, Gerald"'
Search Results
2. Impact of time of admission on short- and long-term mortality in the Vienna STEMI registry
3. Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro
4. Distribution of clinical events across platelet aggregation values in all-comers treated with prasugrel and ticagrelor
5. Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol
6. Comparison of Transesophageal and Transthoracic Echocardiographic Measurements of Mechanism and Severity of Mitral Regurgitation in Ischemic Cardiomyopathy (from the Surgical Treatment of Ischemic Heart Failure Trial)
7. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)
8. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences
9. Glycoprotein 130 polymorphism predicts soluble glycoprotein 130 levels
10. Long-acting beneficial effect of percutaneously intramyocardially delivered secretome of apoptotic peripheral blood cells on porcine chronic ischemic left ventricular dysfunction
11. Mechanisms of Functional Mitral Regurgitation in Ischemic Cardiomyopathy Determined by Transesophageal Echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial)
12. A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure
13. Usefulness of Hemoglobin Level to Predict Long-Term Mortality in Patients With Asymptomatic Carotid Narrowing by Ultrasonography
14. Time Course of Endothelium-Dependent and -Independent Coronary Vasomotor Response to Coronary Balloons and Stents: Comparison of Plain and Drug-Eluting Balloons and Stents
15. Markers of bone metabolism in premature myocardial infarction (≤ 40 years of age)
16. Drug-Eluting Introducer Sheath Prevents Local Peripheral Complications: Pre-Clinical Evaluation of Nitric Oxide–Coated Sheath
17. Prognostic Value of Pigment Epithelium-Derived Factor in Patients With Advanced Heart Failure
18. Increased Restenosis Rate After Implantation of Drug-Eluting Stents in Patients With Elevated Serum Activity of Matrix Metalloproteinase-2 and -9
19. Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation
20. Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantation
21. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction
22. Diastolic function assessment in clinical practice: The value of 2-dimensional echocardiography
23. Effect of timing of clopidogrel administration on 30-day clinical outcomes: 300-mg loading dose immediately after coronary stenting versus pretreatment 6 to 24 hours before stenting in a large unselected patient cohort
24. Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol
25. Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure
26. Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
27. Assessment of myocardial perfusion by dynamic N-13 ammonia PET imaging: Comparison of 2 tracer kinetic models
28. Doppler Echocardiographic Assessment of Valvular Regurgitation Severity by Measurement of the Vena Contracta: An In Vitro Validation Study
29. Vascular dysfunction after coarctation repair is related to the age at surgery
30. Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity
31. Prostaglandin E 1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism
32. Fibrinolytic Balance of the Arterial Wall: Pulmonary Artery Displays Increased Fibrinolytic Potential Compared with Aorta
33. Normal values for Doppler echocardiographic assessment of heart valve prostheses
34. Relationship between dobutamine response of dyssynergic myocardium and angiographically documented blood supply
35. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils
36. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque
37. Long-term outcome of patients with ventricular septal defect considered not to require surgical closure during childhood
38. Contribution of nicotine to acute endothelial dysfunction in long-term smokers
39. Plasminogen Activator Inhibitor 1 Expression is Regulated by the Inflammatory Mediators Interleukin-1α, Tumor Necrosis Factor-α, Transforming Growth Factor-β and Oncostatin M in Human Cardiac Myocytes
40. Urinary excretion of apolipoprotein(a): relation to other plasma proteins
41. Design and dosimetry of a novel 90y beta source to prevent restenosis after angioplasty
42. Cardiac arrest does not affect survival in post-operative cardiovascular surgery patients undergoing extracorporeal membrane oxygenation
43. Assessment of coronary stenoses by Doppler wires: a validation study using in vitro modeling and computer simulations
44. Artificial neural networks and spatial temporal contour linking for automated endocardial contour detection on echocardiograms: a novel approach to determine left ventricular contractile function
45. Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo
46. BENEFICIAL EFFECTS OF LEVOSIMENDAN ON SURVIVAL IN PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION FOLLOWING CARDIOVASCULAR SURGERY
47. DISCRIMINATORY POWER OF INTENSIVE CARE UNIT SCORING SYSTEMS FOR OUTCOME PREDICTION IN PATIENTS UNDERGOING EXTRACORPOREAL MEMBRANE OXYGENATION FOLLOWING CARDIOVASCULAR SURGERY
48. ASSOCIATION OF VENOARTERIAL EXTRA-CORPOREAL MEMBRANE OXYGENATION CANNULATION SITE WITH WEANING TIME AND SURVIVAL
49. Variation of lipoprotein(a) plasma levels after premature myocardial infarction
50. Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.